4//SEC Filing
Riggs Josh 4
Accession 0001493152-24-021047
CIK 0001642380other
Filed
May 21, 8:00 PM ET
Accepted
May 22, 4:56 PM ET
Size
5.7 KB
Accession
0001493152-24-021047
Insider Transaction Report
Form 4
Riggs Josh
CEO and President
Transactions
- Award
Option to Purchase Common Stock
2024-05-20+90,000→ 90,000 totalExercise: $2.76Exp: 2034-05-20→ Common Stock (90,000 underlying)
Footnotes (1)
- [F1]25% of the options will vest and thereby be exercisable after one year of continuous service from the effective date of grant, and the balance will vest and thereby be exercisable in 36 equal monthly installments commencing one year after the date of grant, subject to continuous service through the applicable vesting date.
Documents
Issuer
Oncocyte Corp
CIK 0001642380
Entity typeother
Related Parties
1- filerCIK 0001956391
Filing Metadata
- Form type
- 4
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 4:56 PM ET
- Size
- 5.7 KB